Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...

The use of weight loss drugs like Ozempic and Wegovy has surged in recent years. But the medications are not foolproof, as ...

Even the Hamburglar didn’t see this one coming.Excessive weight has been a persistent problem in America, where at least one ...

Health-care companies rose amid sales growth optimism. Drug-store chain CVS Health said it has seen complaints of strong push back from patients on its pharmacy-benefit manager's move to favor Novo ...

Denmark-based multinational pharmaceutical company Novo Nordisk will make Wegovy, its approved weight-loss treatment for ...

Hims & Hers (NYSE: HIMS) stock, a prominent player in the booming telehealth sector, has undeniably captured significant investor attention recently. Perhaps you, like many others, have been caught up ...

Novo Nordisk ( NVO 6.12%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky ...

Novo Nordisk's Q1 showed robust sales/EPS growth, fueled by soaring GLP-1 demand in a multi-billion dollar market. Read why I ...

STARING at yet another pregnancy test, Erica Coronado was thrilled but terrified. The 36-year-old had given up hope of a baby after two years of trying and the agony of a stillbirth. So seeing two ...

HANNAH Metcalfe caught a whiff of something very unpleasant and felt her cheeks flush red. “It’s him, he’s farted!” she squealed, pointing at one of the burly blokes ...

Teens are being prescribed Ozempic more than ever before — and some doctors are worried about what the trend could mean.